Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 363

    1.

    Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2007 Jan;30(1):38-42.PMID: 17192330 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2009 Sep;32(9):1603-7. Epub 2009 Jun 1.PMID: 19487644 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

    Diabetes Care. 2006 Mar;29(3):643-9.PMID: 16505520 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

    Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.PMID: 18000175 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS.

    Diabetes Care. 2008 Nov;31(11):2188-92. Epub 2008 Jul 23.PMID: 18650369 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.

    Greenbaum CJ, Cuthbertson D, Krischer JP; Disease Prevention Trial of Type I Diabetes Study Group.

    Diabetes. 2001 Feb;50(2):470-6.PMID: 11272162 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.

    Barker JM, McFann K, Harrison LC, Fourlanos S, Krischer J, Cuthbertson D, Chase HP, Eisenbarth GS; DPT-1 Study Group.

    J Pediatr. 2007 Jan;150(1):31-36.e6.PMID: 17188609 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study.

    Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L.

    Diabetes Care. 2009 Feb;32(2):281-6. Epub 2008 Nov 18.PMID: 19017778 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Assessing the shape of the glucose curve during an oral glucose tolerance test.

    Tschritter O, Fritsche A, Shirkavand F, Machicao F, Häring H, Stumvoll M.

    Diabetes Care. 2003 Apr;26(4):1026-33. Erratum in: Diabetes Care. 2004 Jul;27(7):1855. PMID: 12663568 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Predicting future cardiovascular disease: do we need the oral glucose tolerance test?

    Stern MP, Fatehi P, Williams K, Haffner SM.

    Diabetes Care. 2002 Oct;25(10):1851-6.PMID: 12351490 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans.

    McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY.

    Diabetes Care. 2003 Mar;26(3):758-63.PMID: 12610034 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Fasting proinsulin concentrations predict the development of type 2 diabetes.

    Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN.

    Diabetes Care. 1999 Feb;22(2):262-70.PMID: 10333943 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus.

    Weijers RN, Bekedam DJ, Goldschmidt HM, Smulders YM.

    Clin Chem Lab Med. 2006;44(1):99-104.PMID: 16375594 [PubMed - indexed for MEDLINE]Related articles

    15.

    Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

    Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J.

    Pediatr Diabetes. 2004 Jun;5(2):72-9.PMID: 15189492 [PubMed - indexed for MEDLINE]Related articles

    16.

    Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations.

    Bunt JC, Krakoff J, Ortega E, Knowler WC, Bogardus C.

    Diabetes Metab Res Rev. 2007 May;23(4):304-10.PMID: 17001619 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population.

    Rolandsson O, Hägg E, Nilsson M, Hallmans G, Mincheva-Nilsson L, Lernmark A.

    J Intern Med. 2001 Apr;249(4):279-88.PMID: 11298847 [PubMed - indexed for MEDLINE]Related articles

    19.

    Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes.

    Moore MC, Davis SN, Mann SL, Cherrington AD.

    Diabetes Care. 2001 Nov;24(11):1882-7.PMID: 11679451 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

    Stern MP, Williams K, Haffner SM.

    Ann Intern Med. 2002 Apr 16;136(8):575-81.PMID: 11955025 [PubMed - indexed for MEDLINE]Related articlesFree article